In silico Study of Antiviral Activity of Polyphenol Compounds from Ocimum basilicum by Molecular Docking, ADMET, and Drug-Likeness Analysis

References

• World Health Organization. COVID-19 Weekly Epidemiological Update. Geneva: World Health Organization; 2021.
   Google Scholar
• Junaid K, Qasim S, Yasmeen H, et al. Potential inhibitory effect of vitamins against COVID-19. Comput Mater Contin. 2020;66(1):707–714. doi:10.32604/cmc.2020.012976
   Web of Science ®Google Scholar
• Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: a review. J Infect Public Health. 2020;13:1619–1629. doi:10.1016/j.jiph.2020.07.001
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin D, Sun X, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020;368:409–412. doi:10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar
• El-Demerdash A, Metwaly AM, Hassan A, et al. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19). Biomolecules. 2021;11:460. doi:10.3390/biom11030460
   PubMed Web of Science ®Google Scholar
• Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. EMBO J. 2002;21:3213–3224. doi:10.1093/emboj/cdf327
   PubMed Web of Science ®Google Scholar
• Hu Q, Xiong Y, Zhu GH, et al. The SARS‐CoV‐2 main protease (Mpro): structure, function, and emerging therapies for COVID‐19. MedComm. 2022;3:e151. doi:10.1002/mco2.151
   PubMedGoogle Scholar
• Issa SS, Sokornova SV, Zhidkin RR, Matveeva TV. The main protease of SARS-CoV-2 as a target for phytochemicals against coronavirus. Plants. 2022;11:1862. doi:10.3390/plants11141862
   Google Scholar
• Tiwari S, Dubey N. Traditional medicinal plants as promising source of immunomodulator against covid-19. J Exper Biol Agric Sci. 2020;8:S126–S138. doi:10.18006/2020.8(Spl-1-SARS-CoV-2).S126.S138
   Google Scholar
• Chali BU, Melaku T, Berhanu N, et al. Traditional medicine practice in the context of COVID-19 pandemic: community claim in Jimma zone, Oromia, Ethiopia. Infect Drug Resist. 2021;14:3773. doi:10.2147/IDR.S331434
   PubMed Web of Science ®Google Scholar
• Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 2005;32:811–816. doi:10.1111/j.1440-1681.2005.04270.x
   PubMed Web of Science ®Google Scholar
• Shahrajabian MH, Sun W, Cheng Q. Chemical components and pharmacological benefits of Basil (Ocimum basilicum): a review. Int J Food Propert. 2020;23:1961–1970. doi:10.1080/10942912.2020.1828456
   Web of Science ®Google Scholar
• Brahmi F, Vejux A, Ghzaiel I, et al. Role of diet and nutrients in SARS-CoV-2 infection: incidence on oxidative stress, inflammatory status and viral production. Nutrients. 2022;14. doi:10.3390/nu14112194
   Web of Science ®Google Scholar
• Chaudhary KK, Mishra N. A review on molecular docking: novel tool for drug discovery. Databases. 2016;3:1029.
   Google Scholar
• Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;20:13384–13421. doi:10.3390/molecules200713384
   PubMed Web of Science ®Google Scholar
• Ragi K, Kakkassery JT, Raphael VP, Johnson R. In vitro antibacterial and in silico docking studies of two Schiff bases on Staphylococcus aureus and its target proteins. Future J Pharm Sci. 2021;7:1–9.
   Web of Science ®Google Scholar
• Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066–4072. doi:10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257–W263. doi:10.1093/nar/gky318
   PubMed Web of Science ®Google Scholar
• Nguyen V, Nguyen N, Thi N, Thi C, Truc T, Nghi P, editors. Studies on chemical, polyphenol content, flavonoid content, and antioxidant activity of sweet basil leaves (Ocimum basilicum L.). In: IOP Conference Series: Materials Science and Engineering. IOP Publishing; 2021.
   Google Scholar
• Marc RA, Mureșan V, Mureșan AE, et al. Spicy and aromatic plants for meat and meat analogues applications. Plants. 2022;11:960. doi:10.3390/plants11070960
   Google Scholar
• Jayasinghe C, Gotoh N, Aoki T, Wada S. Phenolics composition and antioxidant activity of sweet basil (Ocimum basilicum L.). J Agric Food Chem. 2003;51:4442–4449. doi:10.1021/jf034269o
   PubMed Web of Science ®Google Scholar
• Aboulaghras S, Sahib N, Bakrim S, et al. Health benefits and pharmacological aspects of chrysoeriol. Pharmaceuticals. 2022;15:973. doi:10.3390/ph15080973
   Web of Science ®Google Scholar
• Baderschneider B, Winterhalter P. Isolation and characterization of novel benzoates, cinnamates, flavonoids, and lignans from Riesling wine and screening for antioxidant activity. J Agric Food Chem. 2001;49:2788–2798. doi:10.1021/jf010396d
   PubMed Web of Science ®Google Scholar
• Yang L, Ding W, Xu Y, et al. New insights into the antibacterial activity of hydroxycoumarins against Ralstonia solanacearum. Molecules. 2016;21:468. doi:10.3390/molecules21040468
   PubMed Web of Science ®Google Scholar
• Kang CK, Seong M-W, Choi S-J, et al. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J Intern Med. 2020;35:728. doi:10.3904/kjim.2020.157
   Web of Science ®Google Scholar
• El-Hoshoudy A. Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation. J Mol Liq. 2020;318:113968. doi:10.1016/j.molliq.2020.113968
   PubMed Web of Science ®Google Scholar
• Mulu A, Gajaa M, Woldekidan HB. The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study. PeerJ. 2021;9:e11590. doi:10.7717/peerj.11590
   PubMed Web of Science ®Google Scholar
• Cheng Y-C, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibition, which causes 50% inhibition (IC_< 50>) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099–3108. doi:10.1016/0006-2952(73)90196-2
   PubMed Web of Science ®Google Scholar
• Ul Qamar MT, Alqahtani SM, Alamri MA, Chen L-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10:313–319. doi:10.1016/j.jpha.2020.03.009
   PubMed Web of Science ®Google Scholar
• Maowa J, Hosen M, Alam A, et al. Pharmacokinetics and molecular docking studies of uridine derivatives as SARS-COV-2 Mpro inhibitors. Phys Chem Res. 2021;9:385–412.
   Web of Science ®Google Scholar
• Duque-Soto C, Borrás-Linares I, Quirantes-Piné R, et al. Potential antioxidant and antiviral activities of hydroethanolic extracts of selected Lamiaceae species. Foods. 2022;11:1862. doi:10.3390/foods11131862
   PubMedGoogle Scholar
• Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem. 2007;7:275–301. doi:10.2174/138955707780059844
   PubMed Web of Science ®Google Scholar
• Falcó I, Randazzo W, Gómez-Mascaraque L, Aznar R, López-Rubio A, Sánchez G. Effect of (−)-epigallocatechin gallate at different pH conditions on enteric viruses. LWT Food Sci Technol. 2017;81:250–257. doi:10.1016/j.lwt.2017.03.050
   Web of Science ®Google Scholar
• Ekins S, Waller CL, Swaan PW, Cruciani G, Wrighton SA, Wikel JH. Progress in predicting human ADME parameters in silico. J Pharmacol Toxicol Methods. 2000;44:251–272. doi:10.1016/S1056-8719(00)00109-X
   PubMed Web of Science ®Google Scholar
• Prasanth D, Murahari M, Chandramohan V, Panda SP, Atmakuri LR, Guntupalli C. In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. J Biomol Struct Dyn. 2021;39:4618–4632. doi:10.1080/07391102.2020.1779129
   PubMed Web of Science ®Google Scholar
• Cabrera-Pérez MÁ, Pham-The H. Computational modeling of human oral bioavailability: what will be next? Expert Opin Drug Discov. 2018;13:509–521. doi:10.1080/17460441.2018.1463988
   PubMed Web of Science ®Google Scholar
• Falcón-Cano G, Molina C, Cabrera-Pérez MÁ. ADME prediction with KNIME: in silico aqueous solubility consensus model based on supervised recursive random forest approaches. ADMET DMPK. 2020;8:251–273. doi:10.5599/admet.852
   PubMedGoogle Scholar
• Khan MF, Nahar N, Rashid RB, Chowdhury A, Rashid MA. Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2). BMC Complement Altern Med. 2018;18:1–15. doi:10.1186/s12906-018-2116-x
   PubMed Web of Science ®Google Scholar
• Alhazmi MI. Molecular docking of selected phytocompounds with H1N1 Proteins. Bioinformation. 2015;11:196. doi:10.6026/97320630011196
   PubMed Web of Science ®Google Scholar
• Lombardo F, Gifford E, Shalaeva MY. In silico ADME prediction: data, models, facts and myths. Mini Rev Med Chem. 2003;3:861–875. doi:10.2174/1389557033487629
   PubMed Web of Science ®Google Scholar
• Smith DA, Beaumont K, Maurer TS, Di L. Volume of distribution in drug design: miniperspective. J Med Chem. 2015;58:5691–5698. doi:10.1021/acs.jmedchem.5b00201
   PubMed Web of Science ®Google Scholar
• Hwang J, Youn K, Ji Y, et al. Biological and computational studies for dual cholinesterases inhibitory effect of zerumbone. Nutrients. 2020;12:1215. doi:10.3390/nu12051215
   PubMed Web of Science ®Google Scholar
• X-l. M, Chen C, Yang J. Predictive model of blood-brain barrier penetration of organic compounds. Acta Pharmacol Sin. 2005;26:500–512. doi:10.1111/j.1745-7254.2005.00068.x
   PubMed Web of Science ®Google Scholar
• Guttman Y, Kerem Z. Computer-aided (in silico) modeling of cytochrome P450-mediated Food–Drug Interactions (FDI). Int J Mol Sci. 2022;23:8498. doi:10.3390/ijms23158498
   PubMed Web of Science ®Google Scholar
• El-Shamy NT, Alkaoud AM, Hussein RK, Ibrahim MA, Alhamzani AG, Abou-Krisha MM. DFT, ADMET and molecular docking investigations for the antimicrobial activity of 6, 6′-Diamino-1, 1′, 3, 3′-tetramethyl-5, 5′-(4-chlorobenzylidene) bis [pyrimidine-2, 4 (1H, 3H)-dione]. Molecules. 2022;27:620. doi:10.3390/molecules27030620
   PubMed Web of Science ®Google Scholar
• Alves VM, Muratov EN, Zakharov A, Muratov NN, Andrade CH, Tropsha A. Chemical toxicity prediction for major classes of industrial chemicals: is it possible to develop universal models covering cosmetics, drugs, and pesticides? Food Chem Toxicol. 2018;112:526–534. doi:10.1016/j.fct.2017.04.008
   PubMed Web of Science ®Google Scholar
• Toropov AA, Toropova AP, Raska JI, Leszczynska D, Leszczynski J. Comprehension of drug toxicity: software and databases. Comput Biol Med. 2014;45:20–25. doi:10.1016/j.compbiomed.2013.11.013
   PubMed Web of Science ®Google Scholar
• Drwal MN, Banerjee P, Dunkel M, Wettig MR, Preissner R. ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res. 2014;42:W53–W58. doi:10.1093/nar/gku401
   PubMed Web of Science ®Google Scholar
• El-Din HMA, Loutfy SA, Fathy N, et al. Molecular docking based screening of compounds against VP40 from Ebola virus. Bioinformation. 2016;12:192. doi:10.6026/97320630012192
   PubMedGoogle Scholar
• Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today. 2004;1:337–341. doi:10.1016/j.ddtec.2004.11.007
   Google Scholar
• Tumilaar SG, Fatimawali F, Niode NJ, et al. The potential of leaf extract of Pangium edule Reinw as HIV-1 protease inhibitor: a computational biology approach. J Appl Pharm Sci. 2021;11:101–110.
   Google Scholar
• Shaji D. Molecular docking studies of human MCT8 protein with soy isoflavones in Allan-Herndon-Dudley syndrome (AHDS). J Pharm Anal. 2018;8:318–323. doi:10.1016/j.jpha.2018.07.001
   PubMed Web of Science ®Google Scholar
• Tallei TE, Tumilaar SG, Niode NJ, et al. Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study. Scientifica. 2020;2020. doi:10.1155/2020/6307457
   Web of Science ®Google Scholar
• Benet LZ, Hosey CM, Ursu O, Oprea TI. BDDCS, the Rule of 5 and drugability. Adv Drug Deliv Rev. 2016;101:89–98. doi:10.1016/j.addr.2016.05.007
   PubMed Web of Science ®Google Scholar